This is a working overview of immunomodulation, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-06 and is reviewed periodically as new material appears.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
| Property | Value | Notes |
|---|---|---|
| Amino acid length | 28 residues | Single chain with an acetylated N-terminus |
| Molecular mass | Approximately 3,108 Da | Small shifts occur with counter-ion and water content |
| Isoelectric point | Around 3.5 | Low value follows from the many acidic residues |
| Parent molecule | N-terminal region of prothymosin alpha | Free circulating form in humans is not firmly established |
| Common synonyms | Thymalfasin; T alpha 1 | Older literature also uses the full spelled-out form |
=== Market withdrawal === Conjugated estrogens oral (Cenestin; synthetic conjugated estrogens) – estrogen (estrogen receptor agonist) – atrophic vaginitis [153] Testosterone transdermal (Intrinsa; Intrinsa CHF; Livensa; Testosterone transdermal TheraDerm MTX; WC3048; WC3049) – androgen (androgen receptor agonist) – female sexual dysfunction [154]
Ernest William Beckett (1856–1917), who became the 2nd Baron Grimthorpe. Helen Louisa Beckett-Denison (1858–1935). Adeline Gertrude Beckett-Denison (1859–1902), who married Sir Frederick Milner, 7th Baronet. Violet Katharine Beckett-Denison (1860–1883), who married Reginald Walkeline Chandos-Pole, grandson of Leicester Stanhope, 5th Earl of Harrington. Maud Augusta Beckett-Denison (1864–1927), who married Lord Henry Nevill (later 3rd Marquess of Abergavenny). William Gervase Beckett (1866–1937), who became Sir Gervase Beckett, 1st Baronet of Kirkdale Manor. Hon. Rupert Evelyn Beckett (1870–1955), who married Muriel Helen Florence Paget, granddaughter of Henry Paget, 2nd Marquess of Anglesey. Beckett died at the age of 64 when he fell under a train at Wimborne. He had arrived at Wimborne railway station to change trains for Bournemouth, and while waiting, he went for a walk. He was walking beside the track on the way back to the station when a strong wind blew his hat off, and he fell almost immediately under the train. His body was cut to pieces and carried some 56 feet. Following his death, Mrs. Gertrude Beatrice Brinkworth alleged she was his mistress and mother of his adopted children and sued his executors. Some money was paid, but the case came before the court, and the jury declared Mrs. Brinkworth's case to be a 'swindle' and rejected her claims even before the evidence in the case had been completed.
== Methods to screen protein–protein interactions == Though there are many methods to detect protein–protein interactions, the majority of these methods—such as co-immunoprecipitation, fluorescence resonance energy transfer (FRET) and dual polarisation interferometry—are not screening approaches.
However, major drawbacks of SMB are the inability of separating a mixture into three fractions and the lack of solvent gradient applicability. In the case of antibodies, the state-of-the-art technique is based on batch affinity chromatography (with Protein A or Protein G as ligands) which is able to selectively bind antibody molecules. In general, affinity techniques have the advantage of purifying biomolecules with high yields and purities but the disadvantages are in general the high stationary phase cost, ligand leaching and reduced cleanability. The MCSGP process can result in purities and yields comparable to those of purification using Protein A. The second application example for the MCSGP prototype is the separation of three MAb variants using a preparative weak cation-exchange resin. Although the intermediately eluting MAb variant can only be obtained with 80% purity at recoveries close to zero in a batch chromatographic process, the MCSGP process can provide 90% purity at 93% yield. A numerical comparison of the MCSGP process with the batch chromatographic process, and a batch chromatographic process including ideal recycling, has been performed using an industrial polypeptide purification as the model system. It shows that the MCSGP process can increase the productivity by a factor of 10 and reduce the solvent requirement by 90%.
Sources: en.wikipedia.org
Nickel is obtained through extractive metallurgy: it is extracted from ore by conventional roasting and reduction processes that yield metal of greater than 75% purity. In many stainless steel applications, 75% pure nickel can be used without further purification, depending on impurities. Traditionally, most sulfide ores are processed using pyrometallurgical techniques to produce a matte for further refining. Hydrometallurgical techniques are also used. Most sulfide deposits have traditionally been processed by concentration through a froth flotation process followed by pyrometallurgical extraction. The nickel matte is further processed with the Sherritt-Gordon process. First, copper is removed by adding hydrogen sulfide, leaving a concentrate of cobalt and nickel. Then, solvent extraction is used to separate the cobalt and nickel, with the final nickel content greater than 86%. A second common refining process is leaching the metal matte into a nickel salt solution, followed by electrowinning the nickel from solution by plating it onto a cathode as electrolytic nickel.
=== Fermentation-produced chymosin === Because of the above imperfections of microbial and animal rennets, many producers sought other replacements of rennet. With genetic engineering it became possible to isolate rennet genes from animals and introduce them into certain bacteria, fungi, or yeasts to make them produce recombinant chymosin during fermentation. The genetically modified microorganism is killed after fermentation and chymosin isolated from the fermentation broth, so that the fermentation-produced chymosin (FPC) used by cheese producers does not contain a GMO or any GMO DNA. FPC is identical to chymosin made by an animal, but is produced in a more efficient way. FPC products have been on the market since 1990 and, because the quantity needed per unit of milk can be standardized, are commercially viable alternatives to crude animal or plant rennets, as well as generally preferred to them in industrial production. Originally created by biotechnology company Pfizer, FPC was the first artificially-produced enzyme to be registered and allowed by the US Food and Drug Administration. In 1999, about 60% of US hard cheeses were made with FPC, which thereafter made up to 80% of the global market share for rennet. By 2017, FPC had 90% of the global market share for rennet. By 2021, animal rennet still found use in some traditional or designated European cheeses but FPC covered 80-90% of the market in the US and UK. The most widely used FPC is produced either by the fungus Aspergillus niger and commercialized under the trademark CHY-MAX by the Danish company Chr.
== Physical description == As in many chemical reactions, chemiluminescence starts with the combining of two compounds, say A and B, to give a product C. Unlike most chemical reactions, the product C converts to a further product, which is produced in an electronically excited state often indicated with an asterisk:
==== Medallists ==== The Reverend Canon William Matthew Adair. Rector, St Columba's Parish, Portadown. For services to the Church of Ireland and to the community in Portadown, County Armagh. Sean Adcock. Master Craftsman. For services to Dry Stone Walling. Rasheed Alawiye. Detective Inspector, Metropolitan Police Service. For services to Policing, and to Diversity and Inclusion. Christopher Allen. For services to the community in Chesterfield, Derbyshire. Dr. Jahangir Alom. Doctor and Campaigner, NHS. For services to Tackling Health Inequalities, particularly during Covid-19. Carl Peter Anglim. Lately Chair, Oxfordshire Youth. For services to Young People. Margaret Helen Archibald. Founder, Everyone Matters. For services to Music. Reverend Margaretha Catharina Maria Armitstead. For services to the community in Littlemore, Oxfordshire. Keith Morton Armour. Fundraiser, Children's Hospices Across Scotland. For Charitable Services. Olive Arnold. For services to the community in Bronington, Shropshire. Robert Arnott. For services to the community in Coventry. Waqas Arshad. Chair, Bradley Big Local. For services to Families with Mental Health Issues in Lancashire. Saeqa Ashraf. For services to Law Enforcement. Reverend Christine Joyce Aspinall. For services to the community in Old Trafford, Greater Manchester. Moses Olawole Ayoola. Director, Estates and Facilities, Lewisham and Greenwich NHS Trust and Guy's and St Thomas' NHS Foundation Trust. For services to Leadership in the NHS. Enid Bacon. Founder, Beck Row Preschool, Bury St Edmunds. For services to Early Education.
In September 2010, Labcorp acquired Genzyme Genetics, formerly a division of Genzyme Corporation, with 9 testing laboratories and approximately 1,900 employees, for $925 million in cash. In February 2011, Labcorp acquired the assets of bankrupt Westcliff Medical Laboratory. The FTC challenged the acquisition but lost in court. In June 2011, Labcorp acquired Canadian central labs partner Clearstone from Czura Thornton, adding laboratories in China, France, Singapore and Canada, and the central laboratory protocol management system APOLLO CLPM. In November 2011, Labcorp acquired more than 90% of the shares of DNA testing company Orchid Cellmark for $85 million. To receive approval of the transaction from the Federal Trade Commission, Labcorp sold parts of Orchid's DNA paternity testing business to DNA Diagnostics Center. In May 2012, Labcorp Clinical Trials sold its European biological sampling kit building operation located in Hamburg to Marken. In August 2012, Labcorp acquired testing lab Medtox Scientific for $241 million. In September 2013, Labcorp acquired MuirLab, the clinical laboratory outreach business of John Muir Health. In November 2014, Labcorp acquired LipoScience, a developer of diagnostic tests based on nuclear magnetic resonance spectroscopy measuring heart disease risk, for $85 million. In December 2014, Labcorp acquired Bode Technology Group, a provider of forensic DNA analysis, DNA collection products, and relationship testing and the largest DNA forensic testing company in the U.S., from SolutionPoint International.
Sources: en.wikipedia.org
. Because of the quadrupolar electrical field used to trap the ions in the axial direction, this relationship is only approximate. The axial electrical trapping results in axial oscillations within the trap with the (angular) frequency
== Primary chloroplast lineages == All primary chloroplasts belong to one of four chloroplast lineages—the glaucophyte chloroplast lineage, the rhodophyte ("red") chloroplast lineage, the chloroplastida ("green") chloroplast lineage, and the amoeboid Paulinella chromatophora lineage. The glaucophyte, rhodophyte, and chloroplastidian lineages are all descended from the same ancestral endosymbiotic event and are all within the group Archaeplastida.
=== Lisa Dearn === Lisa Dearn (Chloe Pirrie) is the deputy energy secretary leading the government inquest against Lumi following its collapse. She presses Robert and Henry with pointed questions about Pierpoint's overvaluation of Lumi, as well as Henry's sexual harassment of his employees. In series 4, Lisa is now Secretary of State for Business and Trade. Her far-left views trouble Lord Norton, who is concerned about the waning influence of legacy media under the new Labour government, and perceives her stance as anti-business. She and Minister for Industry Jennifer Bevan meet with Henry, now CEO of payment processing startup Tender, and CFO Whitney Halberstram, when the two seek regulatory approval for a merger with IBN Bauer Bank. Lisa is skeptical of the merger, deeming it monopolistic and self-serving on Henry's part, but the Prime Minister's chief of staff Ricky Martyn arrives to pressure the regulator into approving the merger lest Labour appear anti-business, with Bevan implied to have engineered the intervention. Government support for Tender forces Lisa to publicly back the company as beneficial to the UK consumer during the launch of its banking app, despite her personal skepticism and disgust for Henry. After news breaks of Tender's fraud, Yasmin plots to pin the company's failure on the Labour government, and circulates a lie in the press that Dearn suppressed an internal memo voicing concerns about Tender while expediting Tender's banking license and regulatory approvals.
== Chemistry == 2C-B, also known as 4-bromo-2,5-dimethoxyphenethylamine, is a substituted phenethylamine of the 2C family, also known as the 4-substituted 2,5-dimethoxyphenethylamines. It is a synthetic analogue of the naturally occurring phenethylamine psychedelic mescaline found in peyote and certain other cacti.
The "Source" in the project's title was later dropped when Valve asked the team to remove it in order to "stem confusion over whether or not [it was] an endorsed or official product", which at the time it was not. Eventually, the team rebranded itself as the Crowbar Collective. Most of the team was distributed across the world and used online collaboration to work remotely, with some limited in-person meetings. Originally based on the version of Source released with Counter-Strike: Source in 2004, the project switched to a more recent version released with Valve's The Orange Box in 2007. This new version included more advanced particle effects, hardware-accelerated facial animation, and support for multi-core processor rendering, amongst other improvements. The team had expected this to be a relatively fast project, with trailers released in 2005 and 2008, and an initial release estimate of late 2009, but by mid-2009, had backed off that date, and changed their expected release date to "when it's done". Wired included the game on their "Vaporware of the Year" lists in 2009 and 2010. In the lead-up to the 2012 release, team member Carlos Montero said that in 2009 that they thought they were going to be able to make that date, but "ended up busting our asses to make that a reality, and we went against a lot of our core values in the process.
Sources: en.wikipedia.org
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.
Prothymosin alpha is a much larger acidic protein, roughly 111 to 113 residues long, and the thymosin alpha-1 sequence matches its N-terminal region. The small peptide is therefore best understood as a fragment of that parent protein rather than a separate gene product.
Trials and clinical reports have examined chronic hepatitis B and C, use as a vaccine adjuvant, and supportive treatment in some immunodeficiency and oncology settings. Results vary by indication, and regulatory approval differs between countries.
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.